Javier Sánchez Ramírez

4PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2023
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy.

Nicola Gaynor, Alfonso Blanco, Stephen F Madden

|Apr 04, 2022
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF.

Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero

|Mar 16, 2020
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.

Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero

|Jun 12, 2019
Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?

Javier Sánchez Ramírez, Mónica Bequet-Romero, Yanelys Morera Díaz

Pageof 1

Frequent Collaborators

1 joint publications

Yanelys Morera Díaz

1 joint publications

Mónica Bequet-Romero

1 joint publications

Marta Ayala Ávila

1 joint publications

Bryan T Hennessy